Products for Research Use Only

Clenbuterol

CAT: 0804-HY-B1615Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B1615Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Clenbuterol (NAB-365) is a β2-adrenergic receptor agonist with an EC50 of 31.9 nM[1]. Clenbuterol is a very potent inhibitor of the lipopolysaccharide (LPS) -induced release of TNF-α and IL-1β. Clenbuterol can inhibit the inflammatory process. Clenbuterol is a bronchodilator[2].
CAS Number
37148-27-9
Product Name Alternative
NAB-365
UNSPSC
12352005
Hazard Statement
H315-H319-H320
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/clenbuterol.html
Purity
99.00
Solubility
10 mM in DMSO
Smiles
CC(C)(NCC(C1=CC(Cl)=C(C(Cl)=C1)N)O)C
Molecular Formula
C12H18Cl2N2O
Molecular Weight
277.19
Precautions
P264-P280-P302+P352-P305+P351+P338-P362
References & Citations
[1]Gilad Barnea, et al. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci U S A. 2008 Jan 8;105 (1) :64-9.|[2]Olga Witkowska-Piłaszewicz, et al. The Effect of the Clenbuterol-β2-Adrenergic Receptor Agonist on the Peripheral Blood Mononuclear Cells Proliferation, Phenotype, Functions, and Reactive Oxygen Species Production in Race Horses In Vitro. Cells. 2021 Apr 17;10 (4) :936.|[3]Min Chen, et al. Clenbuterol Induces Cell Cycle Arrest in C2C12 Myoblasts by Delaying p27 Degradation through β-arrestin 2 Signaling. Int J Biol Sci. 2017 Oct 17;13 (10) :1341-1350.|[4]Nikolaos Mellios, et al. β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A. 2014 Jul 8;111 (27) :9947-52.|[5]A F Lehner, et al. Clenbuterol in the horse: confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration. J Anal Toxicol. May-Jun 2001;25 (4) :280-7.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Citation 01
BioRxiv. 2020 Jan.|Adv Sci (Weinh) . 2021 Dec;8 (24) :e2100808.|Adv Sci (Weinh) . 2025 Oct 17:e03966.|Cell Rep. 2025 Sep 23;44 (10) :116337.|Nat Commun. 2020 Sep 25;11 (1) :4857.|Toxicol In Vitro. 2021 Dec:77:105251.